Curatis Holding AG (XSWX:CURN) Short Interest


XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XSWX:CURN vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Short Interest falls into.


XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price